[1] Fajolu IB,Rotimi-Samuel A,Aribaba OT,et al.Retinopathy of prematurity and associated factors in Lagos,Nigeria[J].Paediatr Int Child Health,2015,35(4):324-328. [2] Smith LEH,Wesolowski E,McLellan A,et al.Oxygen-induced retinopathy in the mouse[J].IOVS,1994,35(l):101-111. [3] Yau GS,Lee JW,Tam VT,et al.Risk factors for retinopathy of prematurity in extremely preterm Chinese infants[J].Medicine (Baltimore),2014,93(28):e314-e314. [4] Ola Didrik Saugstad,Dagfinn Aune.In search of the optimal oxygen saturation for extremely low birth weight infants:a systematic review and Meta-analysis[J].Neonatology,2011,100:1-8. [5] Sapieha P,Joyal JS,Rivera JC,et al.Retinopathy of prematurity:understanding ischemic retinal vasculopathies at an extreme of life[J].Clin Invest,2010,120(9):3022-3032. [6] Ali AA,Hussien NF,Samy RM,et al.Polymorphisms of vascular endothelial growth factor and retinopathy of prematurity[J].Pediatr Ophthalmol Strabismus,2015,52(4):245-253. [7] Hicklin DJ,Ellis LM.Role of the vascular endothelia growth factor pathway in tumor growth and angiogenesis[J].J Clin Oncol,2005,23(5):1011-1027. [8] Shih SC,Ju M,Liu M,et al.Selective stimulation of VEGFR-1 prevents oxygen-induced retinal vascular degeneration in retinopathy of prematurity[J].J Clin Invest,2003,112(1):50-57. [9] Pieh C,Agostinil H,Buschbeckl C,et al.VEGF-A,VEGFR-1,VEGFR-2 and Tie2 levels in plasma of premature infants:relationship to retinopathy of prematurity[J].Br J Ophthalmol 2008,92:689-693. [10] Byrne AM,Bouchier-Hayes DJ,Harmey JH.Angiogenicand cell survival functions of vascular endothelial growthfactor(VEGF)[J].J Cell Mol Med,2005,9(4):777-794. [11] Uyttendaele H,Marazzi G,Wu G,et al.Notch4/int3,amammary protooneegene in all endothelial cell specific mammalian Notch gene[J].Development,1996,122(7):2251-2259. [12] Hellstr MM,Phng LK,Gerhardt H.VEGF and Notch signaling:the yin and yang of angiogenic sprouting[J].Cell Adh Migr,2007,1(3):133-136. [13] Yang C,Guo Y,Jadlowiec CC,et al.Vascular endothelial growth factor-A inhibits EphB4 and stimulates delta-like ligand 4 expression in adult endothelial cells[J].Surg Res,2013,183(1):478-486. [14] Noguera-Troise I,Daly C,Papadopoulos NJ,et al.Blockade of Dll4 inhibits tumour growth by promoting nonproductive angiogenesis[J].Nature,2006,444(7122):1032-1037. [15] Miles KM,Seshadri M,Ciamporcero E,et al.Dll4 blockade potentiates the anti-tumor effects of VEGF inhibition in renal cell carcinoma patient-derived xenografts[J].PLoS One,2014,9(11):e112371. [16] Jakobsson L,Bentley K,Gerhardt H.VEGFRs and Notch:a dynamic collaboration in vascular patterning[J].Biochem Soc Trans,2009,37 (Pt 6):1233-1236. [17] Harrington LS,Sainson RC,Williams CK,et al.Regulation of multiple angiogenic pathways by Dll4 and Notch in human umbilical vein endothelial cells[J].Microvasc Res,2008,75(2):144-154. |